Your browser doesn't support javascript.
loading
Psychedelic-assisted therapy for functional neurological disorders: A theoretical framework and review of prior reports.
Stewart, Benjamin; Dean, Jon G; Koek, Adriana; Chua, Jason; Wabl, Rafael; Martin, Kayla; Davoodian, Naveed; Becker, Christopher; Himedan, Mai; Kim, Amanda; Albin, Roger; Chou, Kelvin L; Kotagal, Vikas.
Afiliação
  • Stewart B; Department of Neurology, University of Michigan, Ann Arbor, MI, USA.
  • Dean JG; Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.
  • Koek A; Department of Neurology, University of Michigan, Ann Arbor, MI, USA.
  • Chua J; Department of Neurology, University of Michigan, Ann Arbor, MI, USA.
  • Wabl R; Department of Neurology, University of Michigan, Ann Arbor, MI, USA.
  • Martin K; Department of Neurology, University of Michigan, Ann Arbor, MI, USA.
  • Davoodian N; National Herbarium of Victoria, Melbourne, VIC, Australia.
  • Becker C; Department of Neurology, University of Michigan, Ann Arbor, MI, USA.
  • Himedan M; Department of Neurology, University of Michigan, Ann Arbor, MI, USA.
  • Kim A; University of Chicago Pritzker School of Medicine, Chicago, IL, USA.
  • Albin R; Department of Neurology, University of Michigan, Ann Arbor, MI, USA.
  • Chou KL; Department of Neurology, University of Michigan, Ann Arbor, MI, USA.
  • Kotagal V; Department of Neurology, University of Michigan, Ann Arbor, MI, USA.
Pharmacol Res Perspect ; 8(6): e00688, 2020 12.
Article em En | MEDLINE | ID: mdl-33280274
ABSTRACT
Functional neurological disorders (FNDs), which are sometimes also referred to as psychogenic neurological disorders or conversion disorder, are common disabling neuropsychiatric disorders with limited treatment options. FNDs can present with sensory and/or motor symptoms, and, though they may mimic other neurological conditions, they are thought to occur via mechanisms other than those related to identifiable structural neuropathology and, in many cases, appear to be triggered and sustained by recognizable psychological factors. There is intriguing preliminary evidence to support the use of psychedelic-assisted therapy in a growing number of psychiatric illnesses, including FNDs. We review the theoretical arguments for and against exploring psychedelic-assisted therapy as a treatment for FNDs. We also provide an in-depth discussion of prior published cases detailing the use of psychedelics for psychosomatic conditions, analyzing therapeutic outcomes from a contemporary neuroscientific vantage as informed by several recent neuroimaging studies on psychedelics and FNDs.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alucinógenos / Transtornos Mentais / Doenças do Sistema Nervoso Tipo de estudo: Diagnostic_studies / Prognostic_studies / Qualitative_research Limite: Adult / Animals / Child / Female / Humans / Male Idioma: En Revista: Pharmacol Res Perspect Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alucinógenos / Transtornos Mentais / Doenças do Sistema Nervoso Tipo de estudo: Diagnostic_studies / Prognostic_studies / Qualitative_research Limite: Adult / Animals / Child / Female / Humans / Male Idioma: En Revista: Pharmacol Res Perspect Ano de publicação: 2020 Tipo de documento: Article